Adtech Pharma developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.
Adtech Pharma has raised $1.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2022.
Adtech Pharma's investors include Ault Global Holdings.
Adtech Pharma is headquartered in Warwick, United States.
Adtech Pharma developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.
Adtech Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adtech Pharma — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/adtech-pharma. Accessed August 14, 2026.
VCBacked. (2022). Adtech Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/adtech-pharma
{{cite web |title=Adtech Pharma — Funding & Investors |url=https://www.vcbacked.co/company/adtech-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated